Active, not recruiting
Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
NCT01189643
- Conditions
- Desmoplastic Small Round Cell Tumor, Desmoplastic Small Round Cell Tumor (DSRCT), Neoplasms, +3 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States